Palisade Bio, Inc.
PALI- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001357459
In the last 90 days, Palisade Bio, Inc. insiders filed 3 open-market purchases and 2 sales; 124 institutions reported holding it in 13F filings for Q2 2026, worth $362.4M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Palisade Bio, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- +1 vs. Q1 2022
- Shares held
- 971.5K
- +92.1K (+10.5%) vs. Q1 2022
- Total value
- $395.0K
- −$535.0K (−57.5%) vs. Q1 2022
- New holders
- 5
- 6 more added
- Sold out
- 4
- 3 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PALI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 124 | $362.4M |
| Q1 2026 | 96 | $261.7M |
| Q4 2025 | 86 | $319.4M |
| Q3 2025 | 12 | $102.8K |
| Q2 2025 | 11 | $57.5K |
| Q1 2025 | 13 | $200.9K |
| Q4 2024 | 10 | $387.7K |
| Q3 2024 | 9 | $347.4K |
| Q2 2024 | 8 | $297.7K |
| Q1 2024 | 16 | $384.6K |
| Q4 2023 | 16 | $158.3K |
| Q3 2023 | 13 | $86.6K |
| Q2 2023 | 11 | $228.7K |
| Q1 2023 | 9 | $29.8K |
| Q4 2022 | 12 | $648.0K |
| Q3 2022 | 33 | $842.0K |
| Q2 2022 | 26 | $395.0K |
| Q1 2022 | 25 | $930.0K |
| Q4 2021 | 28 | $1.70M |
| Q3 2021 | 22 | $2.03M |
| Q2 2021 | 23 | $10.1M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Palisade Bio, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 271,604 | $110.0K | 0.00% | 00.0% | Unchanged |
| Sargent Investment Group, LLC | 240,000 | $98.0K | 0.03% | +110,000+84.6% | Added |
| Geode Capital Management, LLC | 130,017 | $53.0K | 0.00% | +3,081+2.4% | Added |
| Strategic Wealth Designers | 53,129 | $22.0K | 0.01% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 34,230 | $14.0K | 0.00% | +12,930+60.7% | Added |
| Private Advisor Group, LLC | 33,500 | $14.0K | 0.00% | +33,500 | New |
| Two Sigma Securities, LLC | 30,513 | $12.0K | 0.00% | −3,664−10.7% | Reduced |
| State Street Corp | 28,210 | $12.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 30,143 | $12.0K | 0.00% | +24,965+482.1% | Added |
| Northern Trust Corp | 23,186 | $9.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 21,501 | $9.00K | 0.00% | +13,392+165.1% | Added |
| First American Trust, FSB | 20,392 | $8.00K | 0.00% | +20,392 | New |
| Millennium Management LLC | 18,973 | $8.00K | 0.00% | +18,973 | New |
| Wells Fargo & Company | 16,366 | $7.00K | 0.00% | +62+0.4% | Added |
| Buckingham Strategic Wealth, LLC | 11,000 | $4.00K | 0.00% | +11,000 | New |
| Morgan Stanley | 7,009 | $3.00K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 477 | $0 | 0.00% | −20,949−97.8% | Reduced |
| Advisor Group Holdings, Inc. | 1,093 | $0 | 0.00% | −3,007−73.3% | Reduced |
| Bank of America Corp | 3 | $0 | 0.00% | 00.0% | Unchanged |
| Evermay Wealth Management LLC | 53 | $0 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 62 | $0 | 0.00% | 00.0% | Unchanged |
| Sterling Investment Advisors, Ltd. | 5 | $0 | 0.00% | 00.0% | Unchanged |
| Centerpoint Advisors, LLC | 9 | $0 | 0.00% | 00.0% | Unchanged |
| Lindbrook Capital, LLC | 9 | $0 | 0.00% | 00.0% | Unchanged |
| Aspire Private Capital, LLC | 34 | $0 | 0.00% | 00.0% | Unchanged |
| Credit Suisse AG | 3 | $0 | 0.00% | +3 | New |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −69,842−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −36,223−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −21,560−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −983−100.0% | Sold out |